Search for: "Myers Construction, Inc." Results 121 - 140 of 148
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
28 Sep 2009, 1:31 am
Bieffe USA, Inc., 35 F. [read post]
17 Jul 2009, 2:29 pm
(Boston, MA; Edward Tobin, President) Ald Construction, Inc. [read post]
13 Jul 2009, 11:52 am
  According to the Center for Applications of Psychological Types, Inc. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
5 Jun 2009, 7:13 am
” “ Article: Posted in consumer protections, Lawsuits Tagged: Chinese drywall, construction defect, Florida, Linkedin [read post]
27 Feb 2009, 7:00 am
– Address to Joint Session of Congress 24 Feb (Securing Innovation) (Securing Innovation)   US Patents – Decisions Supreme Court rejects Federal Trade Commission’s bid to revive battle with Rambus (Law360) (ContentAgenda) (Hal Wegner) Supreme Court declines petition to review Singleton v Volkswagon regarding transfer of venue under 28 USC §1404(a) (Patent Prospector) (Hal Wegner) CAFC: Affidavit evidence to rebut KSR obviousness: Pivonka v Axelrod (IP… [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Jul 2008, 6:00 pm
Alpharma, Inc., Caligor, Inc.; et al. , a 29-page, 2-1 decision, Judge Riley writes:The Kovachs raise one issue on appeal, which we restate as follows: Whether the trial court erred by entering summary judgment in favor of the Cup Defendants. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP)   Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
16 May 2008, 8:03 am
– Brdo: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 16 June / 1 July:US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - San Francisco / New York: (Patent Docs), 17-20 June: US BIO international convention – San Diego: (Patent Docs), 18-20 June / 9-11 July: US PLI: ‘Fundamentals of patent prosecution 2008: A… [read post]
9 May 2008, 10:30 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Order to transfer myspace.co.uk to MySpace overturned: (Out-Law), (IMPACT), New branding scheme for Ethiopian coffees: (Afro-IP), (IP finance), (IPKat), USPTO to appeal Tafas/GSK v Dudas: (Patent Docs), (Patently-O), (PLI), (Patent Baristas), (Managing Intellectual Property), (IP Law360), (Patent Prospector), (Ladas & Parry), … [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]